For more information, visit: www.miltenyibiotec.com/DE-en/... The field of adoptive cell therapy for solid malignancies have made groundbreaking strides using tumor-infiltrating lymphocytes (TILs). Despite the progress, there are still hurdles to overcome in TIL manufacturing. The journey to success lies in refining manufacturing protocols for a brighter clinical outlook.
Join our webinar and discover the cell manufacturing solutions by Miltenyi Biotec. Learn how to generate tumor-reactive T cells (TRTs) for TIL therapy, all within a standardized and seamlessly automated framework.
The CliniMACS Prodigy® is an automated cell processing platform that enables scalable GMP-compliant manufacturing of cell therapy products, on a single device and within a single process setup.
With the perfect combination of CliniMACS Prodigy Instrument, CliniMACS Prodigy Tubing Sets, various accessories, as well as Reagents and Buffers, the CliniMACS Prodigy Platform provides advanced integrated solutions for streamlining cell processing workflows for a variety of cell types. The complete manufacturing process occurs in a closed system - from starting material to the final cell product. With this flexible technology platform, fully automated cell processing for innovative and complex cell manufacturing protocols becomes a reality.pe your text here
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.